Skip to Content

Invenomic Investor BIVRX

Medalist Rating as of | See Invenomic Investment Hub
  • NAV / 1-Day Return 18.02  /  +0.56 %
  • Total Assets 1.3 Bil
  • Adj. Expense Ratio
    2.480%
  • Expense Ratio 3.330%
  • Distribution Fee Level High
  • Share Class Type No Load
  • Category Long-Short Equity
  • Investment Style Mid Value
  • Min. Initial Investment 5,000
  • Status Limited
  • TTM Yield 2.44%
  • Turnover 140%

USD | NAV as of Mar 18, 2024 | 1-Day Return as of Mar 18, 2024, 10:14 PM GMT+0

Morningstar’s Analysis BIVRX

Will BIVRX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A strong management team and sound investment process underpin Invenomic Investor's Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BIVRX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 26.0
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Us Dollar Broker

76.78 1.2 Bil
Cash and Equivalents

Comcast Corp Class A

3.10 47.8 Mil
Communication Services

Verizon Communications Inc

3.08 47.5 Mil
Communication Services

AT&T Inc

2.95 45.4 Mil
Communication Services

Zoom Video Communications Inc

2.50 38.5 Mil
Technology

PENN Entertainment Inc

2.49 38.4 Mil
Consumer Cyclical

Expedia Group Inc

2.43 37.5 Mil
Consumer Cyclical

Viatris Inc

2.43 37.4 Mil
Healthcare

SS&C Technologies Holdings Inc

2.35 36.2 Mil
Technology

Lyft Inc Class A

2.34 36.1 Mil
Technology